Medical Weight Loss in Mission Viejo — GLP-1 & Semaglutide Programs
Physician-supervised weight loss programs built around FDA-approved GLP-1 medications. Dr. Violeta Recalde, a board-certified physician, manages every patient personally at MedGlo in Mission Viejo, CA.
What Is Semaglutide?
Semaglutide is an FDA-approved GLP-1 receptor agonist medication originally developed for the management of type 2 diabetes and now widely prescribed for chronic weight management. GLP-1 stands for glucagon-like peptide-1, a naturally occurring hormone that your body produces in the gut after eating. This hormone plays a central role in regulating appetite, blood sugar levels, and how quickly food moves through your digestive system.
When administered as a weekly injection, semaglutide mimics the action of GLP-1 at a much higher and more sustained level than the body produces on its own. It works through several mechanisms: it signals the brain's appetite centers to reduce hunger, slows gastric emptying so you feel satisfied longer after meals, and helps regulate insulin secretion to stabilize blood sugar levels throughout the day.
For patients seeking medical weight loss in Mission Viejo, semaglutide has become one of the most studied and effective pharmacologic tools available. Clinical trials have demonstrated meaningful weight reduction when combined with dietary changes and increased physical activity, making it a cornerstone of modern, evidence-based weight management programs.
Ozempic, Wegovy, Mounjaro, Zepbound — What's the Difference?
Ozempic (semaglutide)
Ozempic is the brand name for semaglutide that was originally FDA-approved for type 2 diabetes management. It is administered as a once-weekly subcutaneous injection and is available in several dose strengths. While Ozempic is not FDA-approved specifically for weight loss, physicians may prescribe it off-label for weight management when clinically appropriate. Many patients searching for "Ozempic near me" are looking for a GLP-1 doctor who can evaluate whether semaglutide is a suitable option for their health goals.
Wegovy (semaglutide)
Wegovy contains the same active ingredient as Ozempic — semaglutide — but is specifically FDA-approved for chronic weight management in adults with obesity or who are overweight with at least one weight-related medical condition. Wegovy is dosed at higher levels than Ozempic and follows a structured titration schedule that gradually increases the dose over several months to minimize gastrointestinal side effects.
Mounjaro (tirzepatide)
Mounjaro is a dual-action GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist manufactured by Eli Lilly. By targeting two incretin hormones instead of one, tirzepatide may offer additional metabolic benefits. Originally approved for type 2 diabetes, Mounjaro has shown significant results in clinical weight loss trials and is prescribed off-label for weight management by qualified physicians.
Zepbound (tirzepatide)
Zepbound is the weight-management-specific brand of tirzepatide, FDA-approved for chronic weight management in eligible adults. Like the relationship between Ozempic and Wegovy, Zepbound and Mounjaro share the same active molecule but are approved for different indications. Dr. Recalde can help determine which medication and brand may be most appropriate based on your medical history, insurance coverage, and clinical profile.
Why Physician Supervision Matters
GLP-1 medications are prescription drugs with real physiological effects. They require proper patient screening, dose titration, ongoing lab monitoring, and clinical oversight to use safely. Telehealth-only weight loss programs and medspas that delegate prescribing to mid-level providers without direct physician involvement may not provide the level of medical supervision these medications demand.
At MedGlo, Dr. Violeta Recalde personally evaluates and manages every weight loss patient. Dr. Recalde is a board-certified physician with over 20 years of clinical experience, including extensive work as a hospitalist managing complex medical conditions in hospital settings. Her medical background means she is trained to evaluate the full picture — your metabolic health, cardiovascular risk factors, medication interactions, thyroid function, and other conditions that directly impact both the safety and effectiveness of GLP-1 therapy.
This level of physician involvement is what separates a medically supervised weight loss program from a prescription mill. When you work with a GLP-1 doctor in South Orange County who understands the clinical nuances of these medications, you receive care that is both safer and more tailored to your individual needs.
Who Is a Candidate?
GLP-1 medications for weight management are generally considered for adults who meet certain clinical criteria. The FDA-approved indications for medications like Wegovy and Zepbound include adults with a body mass index (BMI) of 30 or greater (obesity), or adults with a BMI of 27 or greater (overweight) who also have at least one weight-related health condition such as high blood pressure, type 2 diabetes, or elevated cholesterol.
However, candidacy is not determined by BMI alone. Dr. Recalde takes a comprehensive approach during your initial consultation, reviewing your complete medical history, current medications, prior weight loss attempts, family history, and any contraindications. Certain conditions — including a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or a history of pancreatitis — may preclude the use of GLP-1 medications.
Your first consultation at MedGlo is a thorough medical evaluation, not a sales appointment. Dr. Recalde will discuss your health history, review any relevant lab work, and have an honest conversation about whether a GLP-1 program is appropriate for you. If semaglutide or tirzepatide is not the right fit, she will discuss alternative approaches to support your weight management goals.
What to Expect
The medical weight loss program at MedGlo follows a structured, physician-directed process designed to prioritize your safety and long-term success.
Initial Consultation
Dr. Recalde conducts a comprehensive in-person medical evaluation at our Mission Viejo office, including a review of your health history, current medications, previous weight loss efforts, and your goals. This is a thorough clinical visit, not a five-minute telehealth call.
Lab Work & Baseline Assessment
Baseline laboratory testing is ordered to evaluate metabolic markers, thyroid function, kidney and liver health, and other indicators that inform medication selection and dosing. These labs help Dr. Recalde build a complete clinical picture before prescribing.
Prescription & Dose Titration
Once cleared, Dr. Recalde prescribes the appropriate GLP-1 medication and establishes a titration schedule. Dosing starts low and is gradually increased over weeks to minimize side effects such as nausea. She adjusts the titration timeline based on how you respond individually.
Ongoing Monitoring & Support
Regular follow-up appointments allow Dr. Recalde to monitor your progress, manage any side effects, repeat lab work as needed, and adjust your treatment plan. Medical weight loss is not a one-size-fits-all process, and ongoing physician oversight is essential to achieving safe, sustainable results.
Schedule a Weight Loss Consultation
If you are considering semaglutide, tirzepatide, or another GLP-1 medication for weight management, the first step is a medical consultation with Dr. Recalde. She will evaluate your health, discuss your options, and determine whether a GLP-1 program is right for you.
MedGlo is located at 26161 La Paz Rd #105, Mission Viejo, CA 92691, serving patients throughout South Orange County including Ladera Ranch, Rancho Santa Margarita, Lake Forest, Aliso Viejo, and Laguna Niguel.